Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 25, 2008. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the GlaxoSmithKline Annual Investment Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to a specific share transaction notification.
- Transaction Price: £11.64 per share
- Transaction Date: July 17, 2008
- Dividend Re-investment Date: July 10, 2008
Material Changes
The filing reports an increase in the interest of Ms. C. Thomas in Ordinary shares. This increase resulted from the re-investment of dividends paid to shareholders. No other material changes to the company's financial position or operations are disclosed in this specific report.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of a director's shareholding change.
Key Facts for Investor Verification
- Ms. C. Thomas increased her shareholding via the Annual Investment Plan.
- The transaction involved the re-investment of dividends paid on July 10, 2008.
- The purchase price was £11.64 per share on July 17, 2008.
- This filing does not contain financial performance data or strategic updates.